Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers
Home › KY › PAINTSVILLE › PAINTSVILLE HOSPITAL COMPANY, LLC

PAINTSVILLE HOSPITAL COMPANY, LLC

NPI: 1538101688 · PAINTSVILLE, KY 41240 · Anesthesiology Physician · NPI assigned 06/12/2006

Billing Flags · Automated signals — not evidence of fraud
Entity Proliferation

Authorized official COOPER, RANDY controls 18+ related entities in our dataset. Read more

$15.46M
Total Medicaid Paid
443,997
Total Claims
322,465
Beneficiaries
232
Codes Billed
2018-01
First Month
2022-01
Last Month

Provider Details

Authorized OfficialCOOPER, RANDY (SVP FINANCE OP/AUTHORIZED OFFICIAL)
NPI Enumeration Date06/12/2006

Related Entities

Other providers sharing the same authorized official: COOPER, RANDY

ProviderCityStateTotal Paid
JACKSON HOSPITAL CORPORATION JACKSON KY $34.90M
DEMING HOSPITAL CORPORATION DEMING NM $34.61M
HOSPITAL OF LOUISA, INC. LOUISA KY $27.77M
HOSPITAL OF BARSTOW INC BARSTOW CA $16.88M
SAN MIGUEL HOSPITAL CORPORATION LAS VEGAS NM $13.21M
TOOELE HOSPITAL CORPORATION TOOELE UT $11.66M
FORREST CITY ARKANSAS HOSPITAL COMPANY LLC FORREST CITY AR $7.42M
MMC OF NEVADA LLC MESQUITE NV $2.60M
FORT PAYNE HOSPITAL CORPORATION FORT PAYNE AL $2.60M
WILLIAMSTON HOSPITAL CORPORATION WILLIAMSTON NC $2.31M
WAUKEGAN ILLINOIS HOSPITAL COMPANY LLC WAUKEGAN IL $2.30M
SOUTHWEST KIDNEY INSTITUTE VASCULAR CENTER LLC TEMPE AZ $850K
EVANSTON HOSPITAL CORPORATION EVANSTON WY $378K
MARION HOSPITAL CORPORATION MARION IL $220K
ANNA HOSPITAL CORPORATION ANNA IL $217K
NATIONAL HEALTHCARE OF MT VERNON INC MOUNT VERNON IL $158K
RED BUD ILLINOIS HOSPITAL COMPANY LLC RED BUD IL $36K
TOOELE HOSPITAL CORPORATION TOOELE UT $5K

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 123,199 $4.45M
2019 119,938 $4.12M
2020 110,025 $3.50M
2021 87,800 $3.27M
2022 3,035 $117K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
99283 Emergency department visit for the evaluation and management, moderate severity 20,919 16,153 $2.61M
99284 Emergency department visit for the evaluation and management, high severity 10,764 8,295 $2.19M
99285 Emergency department visit for the evaluation and management, high severity with immediate threat to life 7,497 3,903 $2.17M
74176 Computed tomography, abdomen and pelvis; without contrast material 6,607 4,377 $1.37M
70450 Computed tomography, head or brain; without contrast material 5,266 3,260 $509K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple 1,668 1,016 $317K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 4,487 3,480 $275K
G0378 Hospital observation service, per hour 2,960 1,442 $240K
71046 Radiologic examination, chest; 2 views 5,666 3,909 $236K
71250 2,662 1,623 $221K
G0463 Hospital outpatient clinic visit for assessment and management of a patient 4,802 2,088 $192K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 2,660 1,595 $182K
72125 Computed tomography, cervical spine; without contrast material 1,558 1,234 $177K
71045 Radiologic examination, chest; single view 7,935 3,826 $164K
11042 Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm 1,714 817 $159K
80053 Comprehensive metabolic panel 29,626 21,292 $155K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 4,103 1,092 $148K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 8,080 6,099 $148K
99282 Emergency department visit for the evaluation and management, low to moderate severity 1,823 1,577 $142K
72131 1,526 1,107 $142K
99281 Emergency department visit for the evaluation and management, self-limited or minor 3,381 2,900 $140K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 2,059 1,839 $139K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 4,013 3,420 $138K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 13,358 9,101 $133K
36415 Collection of venous blood by venipuncture 48,888 20,930 $132K
96375 Therapeutic injection; each additional sequential IV push 3,637 2,831 $131K
80061 Lipid panel 7,061 5,811 $107K
G0483 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed 818 638 $104K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed 4,369 3,921 $98K
84443 Thyroid stimulating hormone (TSH) 7,250 6,525 $97K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 23,944 19,460 $96K
76705 Ultrasound, abdominal, real time with image documentation; limited 1,251 1,089 $94K
72110 1,176 961 $87K
96361 Intravenous infusion, hydration; each additional hour 3,202 1,748 $83K
77067 Screening mammography, bilateral, including computer-aided detection 1,355 1,199 $73K
70486 326 280 $70K
J1885 Injection, ketorolac tromethamine, per 15 mg 2,782 2,372 $68K
73630 1,409 1,198 $63K
72128 424 324 $63K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete 286 243 $61K
73564 1,222 982 $60K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc 1,801 1,338 $57K
74177 Computed tomography, abdomen and pelvis; with contrast material 210 131 $56K
82607 3,991 3,586 $49K
73130 1,113 968 $48K
73030 1,196 950 $47K
97161 750 682 $45K
72148 Magnetic resonance imaging, lumbar spine; without contrast material 166 160 $44K
93975 406 336 $43K
73610 1,175 959 $40K
80074 1,034 896 $39K
78452 Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress 133 93 $37K
82746 2,968 2,676 $37K
J2405 Injection, ondansetron hydrochloride, per 1 mg 3,680 2,919 $36K
83036 Hemoglobin; glycosylated (A1C) 4,715 4,215 $35K
45378 Colonoscopy, flexible; diagnostic, including collection of specimen(s) 173 129 $33K
87086 Culture, bacterial; quantitative colony count, urine 5,610 4,688 $32K
J0696 Injection, ceftriaxone sodium, per 250 mg 2,526 2,065 $32K
43202 87 46 $29K
J2704 Injection, propofol, 10 mg 1,935 1,617 $28K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type 3,078 2,761 $27K
77080 406 363 $26K
72072 273 220 $26K
J7030 Infusion, normal saline solution , 1000 cc 4,038 2,911 $25K
87070 4,985 3,731 $25K
84484 5,880 4,247 $24K
87040 3,323 2,737 $24K
84681 1,239 1,117 $20K
86738 2,692 2,379 $19K
73110 586 467 $19K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 640 523 $19K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction 2,572 1,766 $19K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour 274 201 $18K
J7120 Ringers lactate infusion, up to 1000 cc 1,699 1,369 $16K
83735 5,421 4,530 $16K
96376 1,003 676 $16K
83880 1,251 995 $15K
84439 2,079 1,856 $15K
81001 5,915 5,205 $15K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour 657 386 $14K
72100 217 173 $14K
87430 2,292 2,107 $14K
72050 309 240 $13K
85027 4,500 3,502 $13K
86140 3,092 2,758 $13K
83525 1,408 1,275 $13K
84550 3,394 3,052 $12K
80048 Basic metabolic panel (calcium, ionized) 3,022 2,346 $12K
85651 3,837 3,432 $12K
84703 3,855 3,315 $12K
84403 598 534 $12K
66984 Extracapsular cataract removal with insertion of intraocular lens prosthesis 17 12 $12K
87081 2,700 2,263 $12K
83690 4,088 3,448 $11K
J2550 Injection, promethazine hcl, up to 50 mg 2,488 2,028 $10K
76536 103 90 $10K
99213 Office or other outpatient visit for the evaluation and management of an established patient, low complexity 696 372 $10K
74018 235 214 $10K
85730 4,066 3,337 $10K
86038 818 741 $9K
82150 3,444 2,936 $9K
83550 1,194 1,034 $9K
85610 4,773 3,579 $9K
95913 32 28 $9K
J3490 Unclassified drugs 1,388 619 $8K
93225 105 88 $8K
83540 1,350 1,161 $7K
73080 161 129 $7K
J2270 Injection, morphine sulfate, up to 10 mg 3,314 2,509 $7K
87186 1,389 1,216 $7K
87075 1,051 801 $7K
82803 869 700 $7K
94760 889 474 $7K
36600 1,242 733 $6K
97010 611 125 $6K
81003 5,879 5,069 $6K
87077 1,546 1,040 $5K
84402 241 220 $5K
82962 2,359 1,530 $5K
J1100 Injection, dexamethasone sodium phosphate, 1 mg 1,894 1,678 $5K
93017 106 91 $5K
90714 615 514 $5K
J0595 Injection, butorphanol tartrate, 1 mg 988 813 $5K
73090 103 85 $5K
82043 932 845 $5K
86431 843 760 $4K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml 261 240 $4K
84702 536 463 $4K
94664 523 448 $4K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine 575 497 $4K
83605 903 726 $4K
71275 Computed tomographic angiography, chest, with contrast material 14 12 $3K
82728 359 297 $3K
93971 43 39 $3K
73562 62 60 $3K
84480 221 205 $3K
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg 1,126 913 $3K
82553 842 689 $3K
82550 1,238 1,040 $3K
84481 186 174 $3K
73560 81 66 $3K
85378 883 759 $3K
73590 96 81 $3K
72040 31 30 $3K
J1020 Injection, methylprednisolone acetate, 20 mg 557 506 $2K
J0690 Injection, cefazolin sodium, 500 mg 267 207 $2K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) 220 121 $2K
87205 936 800 $2K
86677 112 106 $2K
J2785 Injection, regadenoson, 0.1 mg 70 61 $2K
G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed 138 130 $2K
A9500 Technetium tc-99m sestamibi, diagnostic, per study dose 88 76 $2K
J2060 Injection, lorazepam, 2 mg 338 281 $2K
J2250 Injection, midazolam hydrochloride, per 1 mg 1,847 1,511 $1K
C9113 Injection, pantoprazole sodium, per vial 400 295 $1K
J3010 Injection, fentanyl citrate, 0.1 mg 1,501 1,249 $1K
87420 142 133 $1K
G0103 Prostate cancer screening; prostate specific antigen test (psa) 181 99 $1K
93226 63 60 $1K
72192 12 12 $1K
84436 181 164 $1K
87076 266 205 $1K
0012A 74 55 $1K
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) 209 186 $903.42
84154 80 73 $900.74
80320 80 66 $826.13
76642 17 13 $823.41
82140 86 67 $816.04
J0171 Injection, adrenalin, epinephrine, 0.1 mg 95 79 $815.12
0011A 60 53 $781.87
G0482 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed 132 121 $768.23
86318 65 53 $707.63
86701 58 50 $701.86
72220 15 15 $693.02
12001 83 65 $682.60
77065 Tomosynthesis, mammo 17 12 $594.67
80299 130 105 $589.20
C1780 Lens, intraocular (new technology) 17 12 $568.41
76775 15 13 $543.77
96367 61 33 $520.53
J1956 Injection, levofloxacin, 250 mg 34 25 $486.59
J2300 Injection, nalbuphine hydrochloride, per 10 mg 82 67 $440.99
73502 12 12 $420.66
J1200 Injection, diphenhydramine hcl, up to 50 mg 274 241 $397.70
J7050 Infusion, normal saline solution, 250 cc 84 54 $387.79
80076 65 58 $363.79
J2360 Injection, orphenadrine citrate, up to 60 mg 173 153 $348.38
J2920 Injection, methylprednisolone sodium succinate, up to 40 mg 38 24 $327.87
84100 159 121 $291.87
84153 23 13 $198.62
86592 58 52 $178.66
73565 32 20 $161.30
95885 34 27 $160.00
J0330 Injection, succinylcholine chloride, up to 20 mg 57 48 $156.52
99214 Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 12 12 $132.28
G0008 Administration of influenza virus vaccine 20 12 $115.81
80346 16 16 $107.82
90686 34 24 $96.28
80335 15 15 $89.55
G1004 Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program 281 239 $83.97
80329 13 13 $82.30
80348 13 13 $79.66
80372 13 13 $79.30
80367 13 13 $76.66
80361 13 13 $76.66
80354 13 13 $76.66
80365 13 13 $76.66
80362 13 13 $76.66
80373 13 13 $76.66
80338 13 13 $74.34
80332 13 13 $74.34
80369 13 13 $73.42
80368 13 13 $73.38
80366 13 13 $71.34
83992 41 40 $66.56
80342 13 13 $66.46
80358 13 13 $66.02
80324 16 16 $62.90
80353 13 13 $62.02
80339 13 13 $60.58
80357 13 13 $60.46
80359 13 13 $53.02
80371 13 13 $50.02
80360 13 13 $50.02
80375 13 13 $47.50
J2710 Injection, neostigmine methylsulfate, up to 0.5 mg 17 14 $42.73
J1644 Injection, heparin sodium, per 1000 units 55 42 $35.34
J2780 Injection, ranitidine hydrochloride, 25 mg 19 17 $32.85
86308 13 13 $25.22
J1580 Injection, garamycin, gentamicin, up to 80 mg 17 12 $11.65
C9399 Unclassified drugs or biologicals 80 57 $0.00
A9270 Non-covered item or service 77 29 $0.00